| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |